Menu

GlobalSupplyChain

Foxconn Strengthens India Presence Amid Global Asset Shift

Foxconn Strengthens India Presence Amid Global Asset Shift

Foxconn Strengthens India Presence Amid Global Asset Shift

India now holds 11% of Foxconn’s global assets, reflecting a major supply chain diversification strategy by the Taiwanese electronics leader.

Foxconn, the Taiwanese electronics manufacturing giant officially known as Hon Hai Precision Industry Co., is realigning its international investment priorities. The latest company filings indicate that India now represents 11% of Foxconn’s total global assets—a clear sign that the firm is intensifying its focus on India as it seeks to lessen its dependency on Chinese operations.

This development comes at a pivotal moment, as companies around the world reassess their manufacturing and supply chain dependencies due to geopolitical uncertainties, trade barriers, and pandemic-induced disruptions.

India’s Rising Role in Foxconn’s Global Strategy

For years, Foxconn’s operations have been deeply entrenched in China, where it manufactures a majority of its electronics products, including Apple’s iPhones. However, shifts in global trade dynamics, rising production costs in China, and the ongoing U.S.-China tensions have prompted the firm to reconsider its operational blueprint.

India, with its burgeoning tech sector, skilled labor force, and proactive industrial policies, has increasingly become a prime destination for global manufacturing giants. Foxconn’s growing investment in India is not just a reflection of necessity—it’s part of a larger vision to build a more resilient, multi-country production network.

Investments Gaining Momentum Across Indian States

The company has expanded facilities in *Tamil Nadu* and *Karnataka, and initiated new projects in **Telangana*. These include large-scale electronics assembly plants, EV component manufacturing units, and even plans to enter India’s semiconductor ecosystem.

A major catalyst behind this push is India’s Production-Linked Incentive (PLI) scheme, which offers financial benefits to global manufacturers who produce high-value goods locally. With this support, Foxconn has been able to streamline its operations, boost local employment, and contribute to India’s export potential.

The company’s local arm, *Foxconn Hon Hai Technology India Mega Development*, has played a central role in overseeing this transition, acting as the operational hub for its growing Indian ventures.

Strategic Benefits of Expanding in India

Foxconn’s increased asset allocation in India brings multiple strategic advantages. Firstly, it provides the company with *geographical diversification*, reducing overexposure to any single country or political environment. Secondly, India’s growing domestic market—one of the largest for smartphones and consumer electronics—offers an additional growth frontier beyond export markets.

The nation has already seen a significant uptick in electronics exports, and major players like Foxconn are accelerating this trend by bringing advanced manufacturing technologies and processes to Indian soil.

Navigating Challenges in a New Environment

Despite its advantages, India is not without its challenges. Additionally, India is still working to match China’s scale, speed, and supply chain efficiency.

The company has demonstrated flexibility and adaptability, often adjusting project timelines or relocating facilities to more industry-friendly states.

What This Means for the Global Tech Supply Chain

It’s no longer just about cheaper labor—it’s about creating *agile, diversified, and resilient* production ecosystems.

This shift is part of a broader trend where tech giants are hedging risks and investing across multiple geographies. In this context, India stands out due to its vast market potential, improving business environment, and government-backed industrial incentives.

As Foxconn continues to build out its Indian capabilities, it’s likely that more global companies will follow suit, further cementing India’s role in the next era of high-tech manufacturing.

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Sudarshan Pharma Eyes Fundraising, Board Meet on June 19

Nvidia Surpasses Apple, Becomes Most Valuable Ever!

India's Role in Apple's Future: A New Era of iPhone Exports Amid Tariff Pressures

India’s Role in Apple’s Future: A New Era of iPhone Exports Amid Tariff Pressures

Apple increases iPhone exports from India to the US as tariffs on Chinese products climb, highlighting a major shift in its global manufacturing strategy.

Apple Shifts Global Strategy to Navigate Growing Tariff Pressures

Apple’s supply chain is undergoing a significant transformation as the tech giant increasingly pivots its manufacturing focus towards India. Recent trade data highlights that almost the entirety of Foxconn’s iPhone exports from India between March and May 2025 were directed to the United States. This sharp change is a direct response to rising tariffs on Chinese-made products, compelling Apple to diversify its production footprint.

Customs records show that Foxconn, one of Apple’s key manufacturing partners, exported iPhones worth approximately $3.2 billion from India during this three-month window. Remarkably, around 97% of these shipments were sent to the US market. This represents a massive jump from 2024 figures, where roughly half of India’s iPhone exports found their way to American consumers.

The surge underscores Apple’s urgent push to counter the increasing costs associated with importing Chinese-made goods into the US—a strategic pivot that could reshape the tech supply landscape for years to come.

iPhone Shipments to the US Reach Record Levels

Partnering in this production surge, Tata Electronics—a division of the Tata Group—has swiftly ramped up its iPhone manufacturing capabilities. May 2025 alone witnessed nearly $1 billion worth of Indian-assembled iPhones landing in the US. While this figure slightly trails the all-time high of $1.3 billion recorded in March, it reflects the sustained momentum behind Apple’s shift.

What’s driving this rapid escalation is clear: geopolitical tensions and shifting trade dynamics. With the Biden administration intensifying its stance on Chinese imports—continuing a policy stance that began under the Trump presidency—Apple has found itself needing to recalibrate its global manufacturing strategy swiftly.

Currently, Chinese tech goods face tariff rates of up to 55% under the proposed framework, making Indian exports far more cost-effective for Apple. While India itself is navigating its own tariff environment—with a base rate of 10% and discussions underway to prevent an additional 26% duty—the conditions remain far more favorable compared to China.

Political Challenges Loom Over Apple’s India Expansion

Apple’s strategic move hasn’t escaped the attention of American political figures. Highlighting a previous conversation with CEO Tim Cook, former President Trump condemned Apple’s deepening investment in India, urging the company to prioritize US production. Regardless of this criticism, Apple seems firmly committed to strengthening its operations in India.

This determination is not without reason. Apple’s goal is to secure a reliable manufacturing base outside China while keeping its largest consumer market, the US, well supplied. For Apple, India provides both the scale and cost advantages necessary to meet that demand while mitigating the risks associated with escalating US-China trade frictions.

Foxconn and Tata Electronics Fuel India’s Growing iPhone Export Surge to America

Leading this transition is Foxconn, Apple’s long-standing production partner. Within the initial five months of 2025 alone, Foxconn’s iPhone exports from India to the US reached $4.4 billion—eclipsing the total $3.7 billion exported throughout all of 2024.

Apple’s aggressive export push has involved chartering dedicated cargo flights. During March 2025, Apple utilized exclusive cargo flights to deliver iPhone models 13, 14, 16, and 16e, with the shipment’s worth nearing $2 billion. The company has also pressed Indian authorities to streamline customs procedures at Chennai airport, successfully reducing clearance times from 30 hours to just six hours.

Tata Electronics, a subsidiary of India’s Tata Group, has rapidly expanded its role in assembling iPhones, working alongside Foxconn in this manufacturing push. Between March and April this year, around 86% of Tata’s iPhone shipments were sent to the United States—a dramatic increase from its 2024 average of just over 50%. Tata, which began exporting iPhones only in mid-2024, has quickly established itself as a key player in Apple’s global manufacturing network.

India’s Growing Role in Global iPhone Production

This shift reflects a larger global trend in Apple’s supply chain reconfiguration. India Accounted for Nearly One-Fifth of Global iPhone Production in 2024 That figure is projected to climb to 25–30% in 2025, signaling India’s rising importance within Apple’s long-term strategy.

The US remains Apple’s largest market for iPhone sales, with American consumers purchasing over 60 million units annually. Historically, about 80% of these devices were manufactured in China. With geopolitical instability showing no signs of abating and tariffs making Chinese goods less competitive, Apple’s gradual transition to Indian assembly hubs looks poised to accelerate.

Final Thoughts

Apple’s decision to increasingly source its iPhone production from India reflects both practical business considerations and geopolitical necessity. With soaring tariffs on Chinese technology imports and ongoing US-China tensions, India has emerged as Apple’s favored alternative.

The remarkable growth of iPhone exports from India to the US in just the first half of 2025 signals a long-term shift, not just a temporary fix. Foxconn’s ramped-up output and Tata’s rapid rise as a major assembler further cement India’s role in Apple’s global supply chain.

While political pressure from US leaders may continue, Apple’s immediate priority is securing reliable, tariff-efficient manufacturing to serve its loyal American customer base. As this trend gathers momentum, India’s prominence as a key player in the global electronics manufacturing ecosystem will only strengthen.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

India’s Forex Reserves Hit $5.2 Billion Surge!

Kaynes Technology Faces Investor Scrutiny as CEO Steps Down Despite Strong Fundamentals

Tata Electronics Sets Sights on Malaysia for Chip Fab Acquisition

Tata Electronics Sets Sights on Malaysia for Chip Fab Acquisition

Indian conglomerate Tata Electronics is nearing an agreement to acquire a semiconductor plant in Malaysia, seeking to accelerate its global expansion and enhance technical capabilities ahead of significant chip manufacturing ventures planned in India.

Introduction
As the global semiconductor race intensifies, Tata Electronics is preparing to make a landmark overseas investment. The company is in advanced discussions to acquire a semiconductor fabrication or OSAT facility in Malaysia, a country recognized for its deep expertise in chip assembly, testing, and packaging. This acquisition is poised to accelerate Tata’s learning curve and operational readiness as it prepares to launch large-scale chip manufacturing operations in India.

Why Malaysia? The Strategic Rationale
Malaysia is recognized as a favoured hub for semiconductor manufacturing due to several factors:
• Mature Ecosystem: The country boasts a well-established base of chip fabrication, assembly, and testing facilities, supported by decades of industry experience.
• Skilled Workforce: Malaysia offers a deep pool of technical talent, from engineers to operators, essential for high-precision semiconductor processes.
• Government Support: Proactive policies and incentives have made Malaysia a magnet for global electronics and semiconductor firms.
• Proximity to Supply Chains: Its location within ASEAN provides easy access to critical suppliers and customers in the region.
For Tata Electronics, entering Malaysia is not just about acquiring assets—it’s about tapping into a knowledge-rich environment that can help the company leapfrog the steep learning curve of semiconductor manufacturing.

The Acquisition Targets
According to sources, Tata Electronics is in negotiations with key Malaysian semiconductor companies, among them:
• DNeX’s SilTerra: A leading local foundry with advanced capabilities in chip fabrication and packaging.
• Globetronics Technology: Known for its expertise in assembly and testing, offering a relatively low entry cost for acquirers.
• X-Fab: An international company operating in Malaysia, focused on mixed-signal semiconductor foundry services.
These potential targets offer Tata an opportunity to acquire not just physical infrastructure, but also operational expertise, established client relationships, and a trained workforce.

Leadership and Execution
The acquisition initiative is spearheaded by KC Ang, the recently appointed president of Tata Semiconductor Manufacturing. Ang brings over three decades of experience in the global foundry business, including senior leadership roles at Global Foundries and SilTerra Malaysia. His deep industry knowledge and local connections are seen as crucial to the success of Tata’s Malaysia foray.

Boosting India’s Semiconductor Ambitions
Tata Electronics’ initiative is directly connected to its bold expansion plans in India:
• Dholera, Gujarat: Tata has committed ₹91,000 crore to build a greenfield chip fabrication plant, aiming to establish India as a major semiconductor hub.
• Morigaon, Assam: An additional ₹27,000 crore is earmarked for an OSAT facility, focusing on chip assembly and packaging.
By acquiring a running facility in Malaysia, Tata aims to import best practices, technical know-how, and managerial expertise to its Indian operations, reducing execution risk and accelerating project timelines.

Impact on Malaysia’s Tech Sector
Industry analysts believe Tata’s entry could significantly boost Malaysia’s standing in the global semiconductor value chain. The acquisition is expected to:
• Strengthen Malaysia’s position in the market for chip packaging, assembly, and testing services.
• Attract further foreign investment and technology partnerships.
• Generate new jobs and upskilling opportunities for the local workforce.
Given the ongoing US-China trade tensions and shifting global supply chains, Malaysia’s role as a semiconductor hub is set to grow, with Tata’s investment adding further momentum.

Apple, India, and the Global Supply Chain
Tata Electronics’ rising profile is also tied to its growing role in Apple’s global supply chain. As Apple diversifies its manufacturing footprint away from China, India—powered by Tata’s capabilities—is emerging as a key alternative. Tata’s expertise in electronics manufacturing and assembly for Apple’s iPhone has already positioned it as a competitor to established giants like Foxconn.

Challenges and the Road Ahead
While the acquisition promises significant benefits, Tata Electronics will need to navigate:
• Regulatory approvals in both Malaysia and India.
• Integration of new teams and processes.
• Alignment with Tata’s long-term vision for semiconductor self-reliance.
The company’s leadership, deep pockets, and strategic clarity, however, provide a solid foundation for overcoming these hurdles.

Conclusion
Tata Electronics’ planned acquisition of a Malaysian chip fab or OSAT facility marks a bold step in its quest to become a global semiconductor powerhouse. By leveraging Malaysia’s strengths and channeling that expertise into its Indian ventures, Tata is positioning itself—and India—at the forefront of the next wave of semiconductor innovation. The move is set to reshape both the Indian and Malaysian tech landscapes, signaling a new era of cross-border collaboration in high-tech manufacturing.

 

 

The image added is for representation purposes only

Iron Path Capital Launches Materials Platform with Partnership

Murae Organisor Reports Promising Q1 2026 Results: A Positive Start to the Fiscal Year

CSL Strategizes to Shield Lifesaving Therapies from Tariff Impacts

CSL Strategizes to Shield Lifesaving Therapies from Tariff Impacts

 

In the face of escalating global trade tensions, Australian biotechnology leader CSL Limited is proactively maneuvering to safeguard its critical therapies from potential tariff repercussions. With a diversified manufacturing footprint and strategic investments, CSL aims to ensure uninterrupted access to its essential medical products worldwide.

Global Manufacturing Footprint as a Buffer

CSL’s Chief Executive Officer, Paul McKenzie, has expressed confidence that approximately 85% of the company’s U.S. operations will remain unaffected by impending pharmaceutical tariffs. This resilience is largely attributed to CSL’s substantial domestic production capabilities and significant investments within the United States. However, McKenzie acknowledged that around 10% of U.S. sales, particularly advanced kidney treatments imported from Europe, could face tariff-related challenges.
The company’s robust manufacturing presence spans across the U.S., Europe, and Australia, enabling it to mitigate risks associated with regional trade policies. This global distribution not only enhances supply chain resilience but also positions CSL to adapt swiftly to shifting regulatory landscapes.

Investment in Supply Chain Resilience

In response to vulnerabilities exposed during the COVID-19 pandemic, CSL has intensified efforts to fortify its supply chain. According to McKenzie, the company’s strategy is centered around building redundancy, flexibility, and responsiveness across all operational fronts. This approach not only protects the business from geopolitical shocks but also reinforces its capacity to meet growing global demand for its lifesaving therapies.
Notably, CSL operates a state-of-the-art $900 million plasma facility in Melbourne, which recently began the approval process for exporting albumin—a plasma-derived product—to China. This move is a part of CSL’s broader strategy to tap into Asia’s expanding healthcare market while also lessening reliance on any single production geography.

Tariffs and Exemptions: A Mixed Outlook

While the threat of pharmaceutical tariffs looms large, CSL has found some relief through recent product exemptions issued by U.S. trade regulators. These exemptions signal a favorable outlook for companies with strong domestic operations and a demonstrable contribution to public health infrastructure.
Nevertheless, CSL is proceeding with caution. The company understands that policy shifts can occur rapidly and unexpectedly, especially in an election year. Therefore, a key part of its strategic planning involves scenario modeling and risk assessment to stay ahead of possible policy changes.

Continued Investment in R&D

Despite the uncertainty surrounding tariffs, CSL remains committed to innovation. The company has maintained its annual research and development (R&D) budget of $1.6 billion, a move that underscores its long-term vision and patient-centric mission. These funds are allocated toward developing novel therapies across immunology, hematology, respiratory health, and transplant medicine.
CSL’s consistent investment in R&D has enabled it to bring life-changing products to market while also exploring cutting-edge technologies such as gene and cell therapies. The company believes that innovation is not just a competitive edge, but a moral imperative in its mission to save lives.

Strategic Divestment in China

In a parallel development, CSL has agreed to divest its plasma collection and fractionation operations in China for $185 million. This move is in line with the company’s long-term strategy to streamline its global operations and concentrate resources in regions with greater strategic importance. The divestment will allow CSL to focus on its high-value markets while maintaining strong collaborative ties with Chinese regulators and partners.
According to company statements, the proceeds from the sale will be reinvested into core growth areas, including infrastructure upgrades, talent acquisition, and product development. CSL is confident that these reinvestments will bolster its competitive positioning and further insulate it from international market volatility.

Future Outlook

Looking ahead, CSL appears well-positioned to navigate the complexities of international trade. The company’s diversified manufacturing base, investment in resilience, and unwavering commitment to innovation are key pillars of its success. While uncertainties remain—particularly around tariff implementation and global regulatory shifts—CSL’s proactive strategy is likely to pay dividends in maintaining both operational stability and patient access to vital therapies.
For global biotech companies like CSL, the road ahead will demand a blend of agility, foresight, and collaboration. And if CSL’s recent actions are any indication, it is ready to lead by example.

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Barclays Sues Ex-Banker Over £3.5M Benefits